Irinotecan, Capecitabine and Oxaliplatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan, Capecitabine and Oxaliplatin, covering 2019-02-25 to 2019-02-25. Get the full timeline:
Most recent: Clinical Trial Update: First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. [Phase 2]